Global Corporate Affairs Archives | Page 20 of 1095 | Be Korea-savvy

Archive by category Global Corporate Affairs

Digital Realty Announces Access to Oracle Cloud Infrastructure in Singapore via FastConnect

Digital Realty Announces Access to Oracle Cloud Infrastructure in Singapore via FastConnect

SINGAPORE, Dec. 07, 2025 (Korea Bizwire) – Digital Realty (NYSE: DLR), the largest global provider of cloud- and carrier-neutral data center, colocation, and interconnection solutions and an Oracle Partner, today announced it will offer connectivity to an Oracle Cloud Infrastructure (OCI) FastConnect point-of-presence (PoP) within the Oracle Cloud Singapore West Region. In addition to the new connectivity, [...]

Miltenyi Biomedicine presents primary analysis of the pivotal DALY 2-EU trial for second-line relapsed/refractory large B-cell lymphoma at the 67th American Society of Hematology (ASH) Annual Meeting

Miltenyi Biomedicine presents primary analysis of the pivotal DALY 2-EU trial for second-line relapsed/refractory large B-cell lymphoma at the 67th American Society of Hematology (ASH) Annual Meeting

DALY 2-EU results show zamtocabtagene autoleucel (zamto-cel) demonstrated clinically meaningful superiority over chemoimmunotherapy in patients with relapsed/refractory large B-cell lymphoma (r/r LBCL)1 Zamto-cel was well-tolerated in the majority of patients. DALY 2-EU included a high-risk study population, characterized by older age and clinically high-risk disease features A 12-day manufacturing time resulted in a vein-to-vein time [...]

CAPHRA Raises Alarm over Legitimacy of WHO Tobacco Treaty

CAPHRA Raises Alarm over Legitimacy of WHO Tobacco Treaty

MANILA, Philippines, Dec. 08, 2025 (Korea Bizwire) – A damning analysis from the Coalition of Asia Pacific Tobacco Harm Reduction Advocates (CAPHRA), entitled “The FCTC Secretariat’s Deepening Legitimacy Problem”, exposes how the World Health Organization’s Framework Convention on Tobacco Control has been captured by American philanthropist-funded NGOs, fundamentally undermining the treaty’s credibility and harming global public health [...]

Io Therapeutics presents today at the American Society for Hematology Annual Meeting, preclinical studies demonstrating combination treatment with BCMA CAR-T cells plus the company’s RXR agonist compound IRX4204 has synergistic efficacy against human multiple myeloma

Io Therapeutics presents today at the American Society for Hematology Annual Meeting, preclinical studies demonstrating combination treatment with BCMA CAR-T cells plus the company’s RXR agonist compound IRX4204 has synergistic efficacy against human multiple myeloma

SPRING, Texas, Dec. 06, 2025 (Korea Bizwire) – Io Therapeutics, Inc., a privately held pharmaceutical company headquartered in Spring, Texas; announced today collaborative presentations at the 67th American Society of Hematology Annual Meeting and Exposition, in Orlando, Florida; with scientists from the Duke University School of Medicine in Durham, North Carolina; reporting data from preclinical studies [...]

Toripalimab Presents Long-Term Survival Benefits as 1st-line Treatment for Advanced Nasopharyngeal Carcinoma and Esophageal Squamous Cell Carcinoma Patients

Toripalimab Presents Long-Term Survival Benefits as 1st-line Treatment for Advanced Nasopharyngeal Carcinoma and Esophageal Squamous Cell Carcinoma Patients

Long-term OS follow-up analysis of JUPITER-02 demonstrates significantly better and clinically meaningful improvement with toripalimab plus chemotherapy as 1st-line treatment for R/M NPC, achieving mOS of 64.8 months and a 5-year OS rate of 52.3%. Torpalimab plus chemotherapy has been approved in over 40 countries, representing the new standard of care for the 1st line treatment [...]

Junshi Biosciences Announces Acceptance of the NDA for Roconkibart (IL-17A) for the Treatment of Moderate to Severe Plaque Psoriasis

Junshi Biosciences Announces Acceptance of the NDA for Roconkibart (IL-17A) for the Treatment of Moderate to Severe Plaque Psoriasis

SHANGHAI, Dec. 05, 2025 (Korea Bizwire) – Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the new drug application (“NDA”) for the company’s product, roconkibart injection (a recombinant humanized anti-IL-17A monoclonal antibody injection, product code: [...]

Yachting: Monaco, 7th ‘Superyacht Chef Competition’ opens for entries

Yachting: Monaco, 7th ‘Superyacht Chef Competition’ opens for entries

MONACO, Dec. 05, 2025 (Korea Bizwire) – Preparations are underway at the Yacht Club de Monaco, which has opened applications for the 7th ‘Superyacht Chef Competition’, organised with Bluewater and scheduled for 2 April 2026. The initiative, led by La Belle Classe Academy, places the spotlight on chefs who shape the onboard experience on superyachts, [...]

Bitget Releases Major Upgrades to GetAgent With Smarter Responses and Free Access for All Users

Bitget Releases Major Upgrades to GetAgent With Smarter Responses and Free Access for All Users

VICTORIA, Seychelles, Dec. 05, 2025 (Korea Bizwire) – Bitget, the world’s largest Universal Exchange (UEX), today announced a major upgrade to GetAgent, its AI-powered trading assistant. The update introduces a more flexible answering engine, a streamlined user interface, and a significant expansion of membership quotas, making advanced AI trading tools more accessible than ever to users across all tiers. GetAgent, [...]

Moonup Technology Partners with European Smart Home Leader Shelly to Showcase Full Smart Building Ecosystem at the 2025 Taipei Building Show

Moonup Technology Partners with European Smart Home Leader Shelly to Showcase Full Smart Building Ecosystem at the 2025 Taipei Building Show

TAIPEI, Taiwan, Dec. 04, 2025 (Korea Bizwire) – Moonup Technology Co., Ltd., the Taiwan operations partner of European smart home leader Shelly (Shelly Group), announced its major participation in the 2025 Taipei Building Show to be held from December 11 to December 14 at Nangang Exhibition Center. The company will present Shelly’s complete smart building [...]

VCI Global Announces Spin-Off of VCCG at US$168 Million Valuation as Part of Dual-Track IPO Strategy

VCI Global Announces Spin-Off of VCCG at US$168 Million Valuation as Part of Dual-Track IPO Strategy

Company to Retain 30% Ownership as VCCG Moves Toward Independent Listing, Unlocking Subsidiary Value and Sharpening VCIG’s Technology-Focused Growth Model KUALA LUMPUR, Malaysia, Dec. 04, 2025 (Korea Bizwire) – VCI Global Limited (NASDAQ: VCIG) (“VCI Global” or the “Company”) today announced that it has approved the spin-off of its capital markets advisory subsidiary, V Capital [...]